$TCRT SEC Filings

Filed On	Filing
23 Oct 2026	8-K: Other Events As previously disclosed, on April 9, 2026, Alaunos Therapeutics, Inc. (the “Company”) received a written notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that...
21 Oct 2026	8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing As previously disclosed, on April 9, 2026, Alaunos Therapeutics, Inc. (the “Company”) received a written notice (the “Deficiency Letter”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) ...
15 Oct 2026	SCHEDULE 13D/A
15 Oct 2026	Form 3: Fairmount Funds Management Llc, Director and 4 others Holds 687,789 shares of Common Stock
15 Oct 2026	SCHEDULE 13D
13 Oct 2026	8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +4 more VALKYRIE Merger Sub II, LLC,a Delaware limited liability company;
09 Oct 2026	8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing As previously disclosed, on April 9, 2026, Alaunos Therapeutics, Inc. (the “Company”) received notice from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company was not in compl...
08 Oct 2026	Form 4: Jerman Michael Allen, Director Received 20,990 shares as a grant or award ($15.6K)
08 Oct 2026	Form 4: Vieser Jaime, Director Received 22,669 shares as a grant or award ($16.9K)
08 Oct 2026	Form 4: Weis Holger, CEO Received 23,564 shares as a grant or award ($17.5K)
08 Oct 2026	Form 4: Postma Robert W, Director Received 21,829 shares as a grant or award ($16.2K)
22 Sep 2026	8-K: Entry into a Material Definitive Agreement; Other Events THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”) is entered into and made effective as of September 18, 2026, between Alaunos Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature...
21 Sep 2026	424B3
17 Sep 2026	8-K: Material Modifications to Rights of Security Holders; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year As used in these By-laws, unless the context otherwise requires, the term:
14 Aug 2026	10-Q
11 Aug 2026	Form 4: Weis Holger, CEO Received 4,363 shares as a grant or award ($8.77K)
27 Jul 2026	Form 4: Jerman Michael Allen, Director Received 8,138 shares as a grant or award ($15.6K)
27 Jul 2026	Form 4: Weis Holger, CEO Received 4,568 shares as a grant or award ($8.77K)
27 Jul 2026	Form 4: Postma Robert W, Director Received 8,463 shares as a grant or award ($16.2K)
27 Jul 2026	Form 4: Vieser Jaime, Director Received 8,789 shares as a grant or award ($16.9K)

Comments